Koyfin Home > Directory > Health Care > Pieris Pharma > Long-term Debt / Equity

Pieris Pharma Long-term Debt / Equity Chart (PIRS)

Pieris Pharma annual/quarterly Long-term Debt / Equity from 2013 to 2020.
  • Pieris Pharma Long-term Debt / Equity for the quarter ending September 09, 2020 was $35m a 14.60% increase of 5m year over year
  • Pieris Pharma Long-term Debt / Equity for the last 12 months ending September 09, 2020 was $35m a 14.60% increase of 5m year over year
  • Pieris Pharma Annual Long-term Debt / Equity for 2019 was $30m a -2,476.00% decrease of -747m from 2018
  • Pieris Pharma Annual Long-term Debt / Equity for 2013 was $777m
Other Ratios Metrics:
  • Pieris Pharma Total Debt / Capital for the quarter ending December 12, 2014 was $7m a -1,250.82% decrease of -82m year over year
  • Pieris Pharma Other Liabilities for the quarter ending September 09, 2018 was $61m a 23.39% increase of 14m year over year
  • Pieris Pharma Total Debt / Equity for the quarter ending December 12, 2014 was $7m
View Chart On Koyfin

Quarterly PIRS Long-term Debt / Equity Data

09/2020$35m
06/2020$32m
03/2020$30m
12/2019$30m
09/2014$-146m
12/2013$777m

Annual PIRS Long-term Debt / Equity Data

2019$30m
2013$777m